{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:13:55Z","timestamp":1785388435118,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bioadv.2025.214185","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:34:31Z","timestamp":1736814871000},"page":"214185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Etoposide-loaded lipopolymer nanoparticles promote Smac minetic activity against inhibitor of apoptosis protein for glioblastoma treatment"],"prefix":"10.1016","volume":"170","author":[{"given":"Yung-Chih","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Kuo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214185_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.biopha.2017.05.125","article-title":"Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review","volume":"92","author":"Anjum","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioadv.2025.214185_bb0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumours","volume":"3","author":"Lesniak","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2025.214185_bb0015","article-title":"Differential predictors and clinical implications associated with long-term survivors in IDH wildtype and mutant glioblastoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fphys.2018.00170","article-title":"Advances in glioblastoma multiforme treatment: new models for nanoparticle therapy","volume":"9","author":"Ozdemir-Kaynak","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cncr.22741","article-title":"Molecularly targeted therapy for malignant glioma","volume":"110","author":"Sathornsumetee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bioadv.2025.214185_bb0030","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","article-title":"Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice","volume":"64","author":"Schimmer","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioadv.2025.214185_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cr.7290046","article-title":"The IAP family: endogenous caspase inhibitors with multiple biological activities","volume":"10","author":"Yang","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.bioadv.2025.214185_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2025.214185_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/febs.13554","article-title":"Inhibitor of apoptosis proteins as intracellular signaling intermediates","volume":"283","author":"Kocab","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bioadv.2025.214185_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.cdd.4402060","article-title":"Caspase function in programmed cell death","volume":"14","author":"Kumar","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioadv.2025.214185_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/febs.13554","article-title":"Inhibitor of apoptosis proteins as intracellular signaling intermediates","volume":"283","author":"Kocab","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bioadv.2025.214185_bb0060","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/JTO.0b013e318226b4a6","article-title":"BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro","volume":"6","author":"Li","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0065","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/biology11111581","article-title":"SMAC mimetic BV6 co-treatment downregulates the factors involved in resistance and relapse of cancer: IAPs and autophagy","volume":"11","author":"Rafat","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.bioadv.2025.214185_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2022.104394","article-title":"Suppressed XIAP and cIAP expressions in human brain cancer stem cells using BV6-and GDC0152-encapsulated nanoparticles","volume":"135","author":"Kuo","year":"2022","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2025.214185_bb0075","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1021\/ja074725f","article-title":"Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP","volume":"129","author":"Sun","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2025.214185_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112615","article-title":"Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma","volume":"133","author":"Kuo","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214185_bb0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2014.12.070","article-title":"Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin-and folic acid-grafted poly (lactide-co-glycolide) nanoparticles","volume":"479","author":"Kuo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214185_bb0090","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioadv.2025.214185_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","article-title":"Cellular response to etoposide treatment","volume":"252","author":"Montecucco","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2025.214185_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.msec.2018.10.094","article-title":"Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid","volume":"96","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2025.214185_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213639","article-title":"Optimized lipopolymers with curcumin to enhance AZD5582 and GDC0152 activity and downregulate inhibitors of apoptosis proteins in glioblastoma multiforme","volume":"154","author":"Kuo","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214185_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtice.2018.03.003","article-title":"Regulation of human brain vascular pericytes and human astrocytes in a blood\u2013brain barrier model using human brain microvascular endothelial cells: expression of TGF-\u03b21, VEGF, MMP-9 and P-gp","volume":"86","author":"Kuo","year":"2018","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2025.214185_bb0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","article-title":"Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol","volume":"192","author":"Yang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214185_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2020.100526","article-title":"Essential oil-loaded nanostructured lipid carriers: the effects of liquid lipid type on the physicochemical properties in beverage models","volume":"35","author":"Bashiri","year":"2020","journal-title":"Food Biosci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0125","article-title":"Cocoa butter and cocoa butter substitute as a lipid carrier of cuminum cyminum L. essential oil; physicochemical properties, physical stability and controlled release study","volume":"314","author":"Pirouzifard","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioadv.2025.214185_bb0130","first-page":"4185","article-title":"Conjugated linoleic acid loaded nanostructured lipid carrier as a potential antioxidant nanocarrier for food applications, food Sci","volume":"8","author":"Hashemi","year":"2020","journal-title":"Nutr"},{"key":"10.1016\/j.bioadv.2025.214185_bb0135","first-page":"22","article-title":"Toxicity of PVA-stabilized silver nanoparticles to algae and microcrustaceans","volume":"3","author":"Becaro","year":"2015","journal-title":"Environ. Nanotechnol. Monit. Manag."},{"key":"10.1016\/j.bioadv.2025.214185_bb0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/slct.202004210","article-title":"pH-sensitive polymeric poly (\u03b5-caprolactone) core-chitosan\/alginate shell particle system for oral insulin delivery","volume":"6","author":"Kalaycioglu","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioadv.2025.214185_bb0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.colsurfb.2016.05.091","article-title":"Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic\u00ae F127 cubosomes","volume":"145","author":"Akhlaghi","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214185_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-015-0128-3","article-title":"Jalali, Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles","volume":"23","author":"Ebrahimi","year":"2015","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0155","first-page":"26","article-title":"Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability","volume":"9","author":"Sood","year":"2013","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/2405461503666180413160954","article-title":"Structural composition of solid lipid nanoparticles for invasive and non-invasive drug delivery","volume":"2","author":"Khatak","year":"2017","journal-title":"Curr. Nanomater."},{"key":"10.1016\/j.bioadv.2025.214185_bb0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijheatmasstransfer.2017.07.094","article-title":"Thermophysical properties of TiO2-PVA\/water nanofluids","volume":"115","author":"Oliveira","year":"2017","journal-title":"Int. J. Heat Mass Transf."},{"key":"10.1016\/j.bioadv.2025.214185_bb0170","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3109\/10717544.2014.948643","article-title":"Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery","volume":"23","author":"Alex","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214185_bb0175","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0142-9612(02)00578-1","article-title":"The production and characteristics of solid lipid nanoparticles (SLNs)","volume":"24","author":"Hou","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214185_bb0180","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/1750-3841.13950","article-title":"Effect of sorbitol plasticizer on the structure and properties of melt processed polyvinyl alcohol films","volume":"82","author":"Tian","year":"2017","journal-title":"J. Food Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nano.2010.06.003","article-title":"Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax","volume":"6","author":"Kheradmandnia","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214185_bb0190","first-page":"112","article-title":"An investigation of molecular structure and dynamics of crude beeswax by vibrational spectroscopy","volume":"15","author":"Zimnicka","year":"2006","journal-title":"Pol. J. Environ. Stud."},{"key":"10.1016\/j.bioadv.2025.214185_bb0195","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1002\/anie.200501837","article-title":"Regiospecific side-chain functionalization of linear low-density polyethylene with polar groups","volume":"44","author":"Bae","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioadv.2025.214185_bb0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3184\/174751914X13983475274161","article-title":"Synthesis of some novel 4-acyl-3-oxo-4-aza-5-pregnene-20E-oxime ester derivatives as potent 5\u03b1-reductase inhibitors","volume":"38","author":"Chen","year":"2014","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.bioadv.2025.214185_bb0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.saa.2013.01.090","article-title":"Electronic absorption, vibrational spectra, nonlinear optical properties, NBO analysis and thermodynamic properties of N-(4-nitro-2-phenoxyphenyl) methanesulfonamide molecule by ab initio HF and density functional methods","volume":"108","author":"Rajamani","year":"2013","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bioadv.2025.214185_bb0210","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/jo202203r","article-title":"Influence of substituents on the through-space shielding of aromatic rings","volume":"77","author":"Anson","year":"2012","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioadv.2025.214185_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.arnmr.2016.07.001","article-title":"The chemical bond: the perspective of NMR spectroscopy","volume":"90","author":"Dracinsky","year":"2017","journal-title":"Annu. Rep. NMR Spectrosc."},{"key":"10.1016\/j.bioadv.2025.214185_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214185_bb0225","first-page":"587","article-title":"Precipitation of solids with dense gases","volume":"9","author":"Knez","year":"2001","journal-title":"Ind. Chem. Libr."},{"key":"10.1016\/j.bioadv.2025.214185_bb0230","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10856-008-3637-5","article-title":"Novel self-assembled amphiphilic poly (\u03b5-caprolactone)-grafted-poly (vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles","volume":"20","author":"Sheikh","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.bioadv.2025.214185_bb0235","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40005-017-0331-y","article-title":"Artemisinin-loaded niosome and pegylated niosome: physico-chemical characterization and effects on MCF-7 cell proliferation","volume":"48","author":"Asgharkhani","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.bioadv.2025.214185_bb0240","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/pharmaceutics12111047","article-title":"Enhancing the oral bioavailability of candesartan cilexetil loaded nanostructured lipid carriers: in vitro characterization and absorption in rats after oral administration","volume":"12","author":"Anwar","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214185_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(00)00442-7","article-title":"Polysaccharide coated liposomes for oral immunization - development and characterization","volume":"203","author":"Venkatesan","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214185_bb0250","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/jps.22174","article-title":"Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility","volume":"99","author":"Alhnan","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0255","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214185_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2007.01.052","article-title":"Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly (n-butyl cyanoacrylate) nanoparticles via miniemulsion","volume":"338","author":"Huang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214185_bb0265","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1016\/j.biomaterials.2013.03.013","article-title":"Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles","volume":"34","author":"Kuo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214185_bb0270","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"PEGylated poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214185_bb0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.bioadv.2025.214185_bb0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cej.2017.12.114","article-title":"Efficient EFGR mediated siRNA delivery to breast cancer cells by cetuximab functionalized Pluronic\u00ae F127\/gelatin","volume":"340","author":"Rafael","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioadv.2025.214185_bb0285","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s12272-011-1016-0","article-title":"Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism","volume":"34","author":"Guan","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioadv.2025.214185_bb0290","series-title":"Nanotoxicology- Materials, Methodologies, and Assessments","first-page":"281","article-title":"Poloxamers as drug-delivery systems: Physicochemical, pharmaceutical, and toxicological aspects","author":"de AraUjo","year":"2014"},{"key":"10.1016\/j.bioadv.2025.214185_bb0295","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3748\/wjg.v24.i29.3222","article-title":"ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: what is the way forward?","volume":"24","author":"Adamska","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/484963","article-title":"Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy","volume":"2015","author":"Hoosain","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2025.214185_bb0305","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioadv.2025.214185_bb0310","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0165-6147(02)01989-2","article-title":"The role of the transferrin\u2013transferrin-receptor system in drug delivery and targeting","volume":"23","author":"Li","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112361","article-title":"Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson\u2019s disease treatment","volume":"129","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2025.214185_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(96)12719-1","article-title":"Autoradiography of transferrin receptors in the human brain","volume":"211","author":"Griffiths","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bioadv.2025.214185_bb0330","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0165-6147(02)01989-2","article-title":"The role of the transferrin\u2013transferrin-receptor system in drug delivery and targeting","volume":"23","author":"Li","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0335","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.18632\/oncotarget.2267","article-title":"Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioadv.2025.214185_bb0340","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2004.02.043","article-title":"A novel apoptotic pathway as defined by lectin cellular initiation","volume":"316","author":"Gastman","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioadv.2025.214185_bb0345","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/mp800218q","article-title":"Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood\u2212brain barrier and survival of brain tumor-bearing animals","volume":"6","author":"Du","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214185_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2024.105637","article-title":"Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus","volume":"163","author":"Kuo","year":"2024","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2025.214185_bb0355","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214185_bb0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jconrel.2022.02.015","article-title":"Recent advances in bio-conjugated nanocarriers for crossing the blood-brain barrier in (pre-) clinical studies with an emphasis on vesicles","volume":"343","author":"Poustforoosh","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214185_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23242","article-title":"Bacterial expression, purification and biophysical characterization of wheat germ agglutinin and its four hevein-like domains","volume":"110","author":"Leyva","year":"2019","journal-title":"Biopolymers"},{"key":"10.1016\/j.bioadv.2025.214185_bb0370","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/app11020884","article-title":"Wheat germ agglutinin\u2014from toxicity to biomedical applications","volume":"11","author":"Balciunaite-Murziene","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.msec.2019.04.065","article-title":"Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44","volume":"102","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2025.214185_bb0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.apsb.2014.03.001","article-title":"Brain tumor-targeted drug delivery strategies","volume":"4","author":"Wei","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioadv.2025.214185_bb0385","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2012.03.014","article-title":"Regulation of apoptosis pathways in cancer stem cells","volume":"338","author":"Fulda","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2025.214185_bb0390","doi-asserted-by":"crossref","first-page":"563","DOI":"10.18632\/oncotarget.191","article-title":"Drug discovery approaches to target Wnt signaling in cancer stem cells","volume":"1","author":"Curtin","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioadv.2025.214185_bb0395","first-page":"89","article-title":"Design of small-molecule Smac mimetics as IAP antagonists, small-molecule inhibitors of protein-protein interactions","volume":"348","author":"Wang","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0400","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/pro.523","article-title":"Recognition of Smac-mimetic compounds by the BIR domain of cIAP1","volume":"19","author":"Cossu","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioadv.2025.214185_bb0405","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/OTT.S33375","article-title":"IAP proteins as targets for drug development in oncology","volume":"2013","author":"Dubrez","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bioadv.2025.214185_bb0410","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.cdd.4402085","article-title":"RIP1, a kinase on the crossroads of a cell's decision to live or die","volume":"14","author":"Festjens","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioadv.2025.214185_bb0415","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0420","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2007.10.042","article-title":"Smac mimetics and TNF\u03b1: a dangerous liaison?","volume":"131","author":"Wu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bioadv.2025.214185_bb0425","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1126\/science.288.5467.874","article-title":"Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli","volume":"288","author":"Yang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bioadv.2025.214185_bb0430","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.molcel.2011.06.006","article-title":"The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs","volume":"43","author":"Tenev","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioadv.2025.214185_bb0435","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/jcmm.17792","article-title":"Tumour induction in BALB\/c mice for imaging studies: an improved protocol","volume":"27","author":"Amini","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioadv.2025.214185_bb0440","article-title":"Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0445","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","article-title":"Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)","volume":"22","author":"Rathore","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioadv.2025.214185_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","article-title":"Cellular response to etoposide treatment","volume":"252","author":"Montecucco","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2025.214185_bb0455","first-page":"165","article-title":"Caspase control: protagonists of cancer cell apoptosis","volume":"34","author":"Fiandalo","year":"2012","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bioadv.2025.214185_bb0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cdd.2011.163","article-title":"IAPs: guardians of RIPK1","volume":"19","author":"Darding","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioadv.2025.214185_bb0465","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/bios13020297","article-title":"Bioluminescent RIPoptosome assay for FADD\/RIPK1 interaction based on split luciferase assay in a human neuroblastoma cell line SH-SY5Y","volume":"13","author":"Ghanavatian","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.bioadv.2025.214185_bb0470","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","article-title":"Drug delivery systems: an updated review","volume":"2","author":"Tiwari","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.bioadv.2025.214185_bb0475","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/10717544.2020.1831106","article-title":"Recent advances in drug delivery systems for enhancing drug penetration into tumors","volume":"27","author":"He","year":"2020","journal-title":"Drug Deliv."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T07:52:47Z","timestamp":1740901967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":95,"alternative-id":["S2772950825000123"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214185","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etoposide-loaded lipopolymer nanoparticles promote Smac minetic activity against inhibitor of apoptosis protein for glioblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214185"}}